Medical device manufacturer Bedfont Scientific will launch its new and improved FeNO monitor exclusively at the world’s largest European Respiratory Society (ERS) Congress.
The second-generation family company has specialised in breath analysis for more than 40 years and will launch its 2nd generation NObreath® next week at the ERS Congress in Paris.
The device is being launched after the recent publication of the NICE guidance on Asthma: diagnosis, monitoring and chronic asthma management, to improve asthma care, which included the NObreath FeNO monitor from Bedfont as a recommended device.
... to continue reading you must be subscribed
